The European 5-year research project AFFIRMO has been recently inaugurated. Ontonix is part of a multidisciplinary consortium across Europe representing clinical research, epidemiology, data science, biostatistics, pharmacology, economics, psychology and social sciences.
The current healthcare approach to multimorbidity is fragmented. AFFIRMO aims to move from fragmentation to an integrated care pathway designed to be Patient-centred, Systemic, Digital and (Predictive).
AFFIRMO will develop, implement and test patient-cantered approach on older multimorbid AF patients in the clinical practice. The proposed approach will rely on a digital platform designed to bring patients, caregivers, and health professionals closer together through information sharing.
An international clinic study will be performed to assess the effectiveness of the AFFIRMO’s care approach. Researchers will also consider the economic dimension by identifying how the integrated pathway will impact health outcomes and costs.
Our QCM technology will be part of the digital platform.
To find out more about AFFIRMO, visit site.